Niflumic acid

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H9F3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U5MP5IUD8, chemically known as 3-pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)- but generally known as niflumic acid, which bears US NIH Compound Identifier 4488. European Medicines Agency schedules Niflumic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09257MIG. The term NIFLUMIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules niflumic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule niflumic acid under HS 29333999 and SITC 51574. As of Q4 2014, NIFLUMIC ACID remains the US FDA Preferred Term for this commodity. Niflumic acid bears US NLM identifiers UMLS ID C0028067 and NCI Concept Code C76807. SMILES: C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.